Brief: ORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners
16/07/2024 22:08
July 16 (Reuters) - Oric Pharmaceuticals Inc ORIC.O :
* ORIC PHARMACEUTICALS ANNOUNCES MULTIPLE CLINICAL
COLLABORATIONS
WITH STRATEGIC PARTNERS TO SUPPORT ONGOING TRIAL EVALUATING
ORIC-944 IN COMBINATION WITH AR INHIBITORS FOR THE TREATMENT OF
PROSTATE CANCER
* ORIC PHARMACEUTICALS INC: ENTERED INTO CLINICAL TRIAL
COLLABORATION & SUPPLY AGREEMENTS WITH BAYER AND JOHNSON &
JOHNSON
Source text for Eikon: ID:nGNXk5nfz
Further company coverage: ORIC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows